Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (βTC-3) cells to glucose-dependent insulinotropic polypeptide

Journal of Endocrinology

Volumn 165, Issue 2, 2000, Pages 281-291

  Hinke, S A ^a   Pauly, R P ^a   Ehses, J ^a   Kerridge, P ^a   Demuth, H U ^b   McIntosh, C H S ^a   Pederson, R A ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PROBIODRUG AG   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL PEPTIDASE; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; PHOSPHODIESTERASE; PROTEIN KINASE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; EXOCYTOSIS; HYPERGLYCEMIA; INSULIN RELEASE; INSULINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034118750     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1650281     Document Type: Article

References (45)

1. Ämmälä C, Ashcroft FM & Rorsman P 1993 Calcium-independent potentiation of insulin release by cyclic AMP in single β-cells. Nature 363 356-358.
2. Attramadal H, Eikvar L & Hansson V 1988 Mechanisms of glucagon-induced homologous and heterologous desensitization of adenylate cyclase in membranes and whole Sertoli cells of the rat. Endocrinology 123 1060-1068.
3. Böhm SK, Grady EF & Bunnett NW 1997 Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochemical Journal 322 1-18.
4. Bolaffi JL, Bruno L, Heldt A & Grodsky GM 1988 Characteristics of desensitization of insulin secretion in fully in vitro systems. Endocrinology 122 1801-1809.
5. Brown JC, Dryburgh JR, Ross SA & Dupré J 1975 Identification and actions of gastric inhibitory polypeptide. Recent Progress in Hormone Research 31 487-532.
6. D'Alessio D 1997 Peptide hormone regulation of islet cells. Hormone and Metabolic Research 29 297-300.
7. Ding W-G & Gromada J 1997 Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic β-cells by glucose-dependent insulinotropic polypeptide. Diabetes 46 615-621.
8. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D & Baekkeskov S 1988 Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Cell Biology 85 9037-9041.
9. Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC & Andres R 1984 The enteric enhancement of glucose stimulated insulin release. The role of GIP in aging, obesity and noninsulin-dependent diabetes. Diabetes 33 950-957.
10. Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, Habener JF & Andersen DK 1994 The insulinotropic actions of glucose dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Regulatory Peptides 51 63-74.
11. Fehmann HC & Habener JF 1991 Homologous desensitization of the insulinotropic glucagon-like peptide-I(7-37) receptor on insulinoma (HIT-T15) cells. Endocrinology 128 2880-2888.
12. Gespach C, Emami S & Rosselin G 1984 Gastric inhibitory polypeptide (GIP), pancreatic glucagon, and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity. Biochemical and Biophysical Research Communications 120 641-649.
13. Grodsky GM 1989 A new phase of insulin secretion. How will it contribute to our understanding of beta-cell function? Diabetes 38 673-678.
14. Gromada J, Dissing S & Rorsman P 1996 Desensitization of glucagon-like peptide-1 receptor in insulin-secreting βTC-3 cells: role of PKA-independent mechanisms. British Journal of Pharmacology 118 769-775.
15. Jia X, Brown JC, Ma P, Pederson RA & McIntosh CHS 1995 Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion. American Journal of Physiology 268 E645-E651.
16. Jones IR, Owens DR, Luzio S & Hayes TM 1989 Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus. Hormone and Metabolic Research 21 23-26.
17. Kesper S, Rucha J, Neve H, Mazenot C & Verspohl EJ 1999 Gαi2-mRNA and -protein regulation as a mechanism for heterologous sensitization and desensitization of insulin secretion. Cellular Signalling 11 759-768.
18. Kieffer TJ, Verchere CB, Fell CD, Huang Z, Brown JC & Pederson RA 1993 Glucose-dependent insulinotropic polypeptide stimulated insulin release from a tumour-derived β-cell line (βTC3). Canadian Journal of Physiology and Pharmacology 71 917-922.
19. Kieffer TJ, McIntosh CHS & Pederson RA 1995 Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136 3585-3596.
20. Kubota A, Yamada Y, Yasuda K, Someya Y, Ihara Y, Kagimoto S, Watanabe R, Kuroe A, Ishida H & Seino Y 1997 Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. Biochemical and Biophysical Research Communications 235 171-175.
21. Lu M, Wheeler MB, Leng X-H & Boyd AE 1993 The role of the free cytosolic calcium level in β-cell signal transduction by gastric-inhibitory polypeptide and glucagon-like peptide I(7-37). Endocrinology 132 94-100.
22. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B & Schuit F 1996 Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic polypeptide receptors in rat pancreatic islet cells. Diabetes 45 257-261.
23. Nauck MA, Bartels E, Orskøv C, Ebert R & Creutzfeldt W 1993a Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1(7-36 amide) infused at near physiological insulinotropic hormone and glucose concentrations. Journal of Clinical Endocrinology and Metabolism 76 912-917.
24. Nauck MA, Heimesaat MM, Ørskov C, Holst JJ, Ebert R & Creutzfeldt W 1993b Preserved incretin activity of glucagon-like peptide-1 (7-36amide), but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation 91 301-307.
25. Pauly RP, Rosche F, Wermann M, McIntosh CHS, Pederson RA & Demuth H-U 1996 Investigation of GIP1-42 and GLP-1 7-36 degradation in vitro by dipeptidyl peptidase IV (DPIV) using matrix-assisted laser desorption/ionization-time of flight mass spectometry (MALDI-TOF MS): a novel kinetic approach. Journal of Biological Chemistry 271 23222-23229.
26. Pauly RP, Demuth H-U, Rosche F, Schmidt J, White HA, Lynn F, McIntosh CHS & Pederson RA 1999 Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor ile-thiazolidide. Metabolism 48 385-389.
27. Pederson RA 1994 Gastric inhibitory polypeptide. In Gut Peptides: Biochemistry and Physiology, pp 217-259. Eds J Walsh & G Dockray. New York: Raven Press, Ltd.
28. Pederson RA, Buchan AMJ, Zahedi-Asl S, Chan CB & Brown JC 1982 Effect of jejunoileal bypass in the rat on the enteroinsular axis. Regulatory Peptides 3 53-63.
29. Pederson RA, White HA, Schlenzig D, Pauly RP, McIntosh CHS & Demuth H-U 1998 Improved glucose tolerance in zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide. Diabetes 47 1253-1258.
30. Poitout V, Olson LK & Robertson RP 1996 Insulin-secreting cell lines: classification, characteristics and potential applications. Diabetes and Metabolism 22 7-14.
31. Renström E, Eliasson L & Rorsman P 1997 Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic B-cells. Journal of Physiology 1997 105-118.
32. Ross SA, Brown JC & Dupré J 1977 Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus. Diabetes 26 525-529.
33. i and a wortmannin-sensitive signalling pathway. Biochemical and Biophysical Research Communications 224 369-374.
34. Thorens B & Widmann C 1996 Signal transduction and desensitization of the glucagon-like peptide-1 receptor. Acta Physiologica Scandinavica 157 317-319.
35. Tseng C-C & Zhang X-Y 1998a The cysteine of the cytoplasmic tail of the glucose-dependent insulinotropic peptide receptor mediates its chronic desensitization and down-regulation. Molecular and Cellular Endocrinology 139 179-186.
36. Tseng C-C & Zhang X-Y 1998b Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor. Endocrinology 139 4470-4475.
37. Tseng C-C, Boylan MO, Jarboe LA, Usdin TB & Wolfe M 1996 Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats. American Journal of Physiology 270 E661-E666.
38. Usdin TB, Mezey É, Button DC, Brownstein MJ & Bonner TI 1993 Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133 2861-2870.
39. Van der Vliet JA, Meloche RM, Field MJ & Chen D 1988 Pancreatic islet isolation in rats with ductal collagenase distention, stationary digestion, and dextran separation. Transplantation 45 493-494.
40. Wheeler MB, Gelling RW, McIntosh CHS, Georgiou J, Brown JC & Pederson RA 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology 136 4629-4639.
41. Wheeler MB, Gelling RW, Hinke SA, Tu B, Chandy MJ, Lynn FC, Ehses J, Pederson RA & McIntosh CHS 1999 Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor: a role for serines 426 and 427 in internalization. Journal of Biological Chemistry 274 24593-24601.
42. Widmann C, Dolci W & Thorens B 1995 Heterologous desensitization of the glucagon-like peptide-1 receptor by phorbol esters requires phosphorylation of the cytoplasmic tail at four different sites. Journal of Biological Chemistry 271 19957-19963.
43. Widmann C, Dolci W & Thorens B 1997 Internalization and homologous desensitization of the GLP-1 receptor depend on phosphorylation of the receptor carboxyl tail at the same three sites. Molecular Endocrinology 11 1094-1102.
44. Zawalich WS, Bonnet-Eymard M & Zawalich KC 1998 Glucose-induced desensitization of the pancreatic β-cell is species dependent. American Journal of Physiology 275 E917-E924.
45. Zhou J & Egan JM 1997 SNAP-25 is phosphorylated by glucose and GLP-1 in RIN 1046-38 cells. Biochemical and Biophysical Research Communications 238 297-300.